Vistagen Therapeutics, Inc.
VTGN· Nasdaq
VTGNVistagen Therapeutics, Inc.
Filed Jun 29, 2015 · 10-K · 90 days after period end · 0001415889-15-002221
| Metric | Q4 2015 | Q4 2014 | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | — | — | $352.73K |
| Net Income | -$6.22M | -$1.83M | -$3.54M |
| EPS Diluted | -$4.24 | -$1.57 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vistagen Therapeutics, Inc. · CIK 1411685 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed Jun 29, 2015 · 90 d after period end
